{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T10:02:11Z","timestamp":1790848931159,"version":"4.1.0"},"reference-count":82,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2002,9,1]],"date-time":"2002-09-01T00:00:00Z","timestamp":1030838400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tumori"],"published-print":{"date-parts":[[2002,9]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>CD40, a cell surface molecule, is expressed on B-cell malignancies and many different solid tumors. It is capable of mediating diverse biological phenomena such as the induction of apoptosis in tumors and stimulation of the immune response. It has thus been studied as a possible target for antitumor therapy. The general aim of this review is to focus the attention of clinical oncologists on the involvement of CD40 in tumors and the rationale of CD40-activation-based therapies in new, biologically oriented antitumor protocols.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A Medline review of published papers about the role of CD40 activation in cancer therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Many authors have shown that CD40 activation promotes apoptotic death of tumor cells and that the presence of the molecule on the surface of carcinoma lines is an important factor in the generation of tumor-specific T-cell responses that contribute to tumor cell elimination. The CD40 ligand (CD40L) is the natural ligand for CD40; it is expressed primarily on the surface of activated T lymphocytes. Preclinical studies suggest that CD40-CD40L interaction could be useful for cytotoxicity against CD40-expressing tumors and for immune stimulation. Tumor inhibition was observed when tumor cells were treated with agonistic anti-CD40 monoclonal antibodies or with the soluble form of CD40L. The results of the first phase I clinical trial to treat cancer patients with subcutaneous injection of recombinant human CD40L have been recently reported. Immunohistochemical studies have revealed that detection of CD40 in primary cutaneous malignant melanoma and lung cancer may have a negative prognostic value. Interestingly, up-regulation of CD40 was observed in the tumor vessels of renal carcinomas and Kaposi's sarcoma, suggesting possible involvement of CD40 in tumor angiogenesis. Recently, it has also been shown that CD40 engagement on endothelial cells induces\n                      <jats:italic>in vitro<\/jats:italic>\n                      tubule formation and expression of matrix metalloproteinases, two processes involved in the neovascularization and progression of tumors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CD40 activation represents an exciting target for hematological malignancies and solid tumors expressing the molecule, but its functional role in cancer development still remains unclear and controversial.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/030089160208800502","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T12:31:10Z","timestamp":1523881870000},"page":"361-366","source":"Crossref","is-referenced-by-count":23,"title":["Cd40 Activation as Potential Tool in Malignant Neoplasms"],"prefix":"10.1177","volume":"88","author":[{"given":"Alessandro","family":"Ottaiano","sequence":"first","affiliation":[{"name":"Division of Medical Oncology B, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"Pisano","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology B, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"De Chiara","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Antonio","family":"Ascierto","sequence":"additional","affiliation":[{"name":"Department of Clinical Immunology, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Botti","sequence":"additional","affiliation":[{"name":"Department of Surgical Pathology, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiddio","family":"Barletta","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology B, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Apice","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology B, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesare","family":"Gridelli","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology, \u201cSan Giuseppe Moscati\u201d Hospital, Monteforte Irpino, Avellino, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo Rosario","family":"Iaffaioli","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology B, National Cancer Institute \u201cG Pascale\u201d, Naples"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2002,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.02593.x"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-199909000-00007"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.67.1.2"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.10.4342"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60865-2"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.288.5475.2351"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80281-2"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1234"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1421"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.46.28745"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.18.9437"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/383443a0"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.271.25.14661"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.275.5297.200"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.18.9792"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0167-5699(94)90269-0"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.270.21.12343"},{"key":"e_1_2_1_19_2","doi-asserted-by":"crossref","first-page":"5527","DOI":"10.4049\/jimmunol.155.12.5527","article-title":"CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth.","volume":"155","author":"Ishida T.","year":"1995","unstructured":"IshidaT. KobayashiN. TojoT. IshidaS. YamamotoT. InoueJ.: CD40 signaling-mediated induction of Bcl-XL, Cdk4, and Cdk6. Implication of their cooperation in selective B cell growth. J Immunol, 155: 5527\u20135535, 1995.","journal-title":"J Immunol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.4049\/jimmunol.158.6.2919","article-title":"Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway.","volume":"158","author":"Verhasselt V.","year":"1997","unstructured":"VerhasseltV. BuelensC. WillemsF. De GrooteD. Haeffner-CavaillonN. GoldmanM.: Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway. J Immunol, 158: 2919\u20132925, 1997.","journal-title":"J Immunol"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.98.4.1751"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830221226"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830250639"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.4.1209"},{"key":"e_1_2_1_25_2","first-page":"405","article-title":"CD40 expression in uterine tissues: a key regulator of cytokine expression by fibroblasts.","volume":"86","author":"King A.E.","year":"2001","unstructured":"KingA.E. KellyR.W. CritchleyH.O. MalmstromA. SennstromM. PhippsR.P.: CD40 expression in uterine tissues: a key regulator of cytokine expression by fibroblasts. J Clin Endocrinol Metab, 86: 405\u2013412, 2001.","journal-title":"J Clin Endocrinol Metab"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-2952(00)00452-4"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.111"},{"key":"e_1_2_1_28_2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.4049\/jimmunol.158.1.144","article-title":"CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation.","volume":"158","author":"Peguet-Navarro J.","year":"1997","unstructured":"Peguet-NavarroJ. Dalbiez-GauthierC. MoulonC. BerthierO. ReanoA. GaucherandM. BanchereauJ. RoussetF. SchmittD.: CD40 ligation of human keratinocytes inhibits their proliferation and induces their differentiation. J Immunol, 158: 144\u2013152, 1997.","journal-title":"J Immunol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)05108-4"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/09537100020031207"},{"key":"e_1_2_1_31_2","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.4049\/jimmunol.156.7.2352","article-title":"T cells commit suicide, but B cells are murdered!","volume":"156","author":"Scott D.W.","year":"1996","unstructured":"ScottD.W. GrdinaT. ShiY.: T cells commit suicide, but B cells are murdered! J Immunol, 156: 2352\u20132356, 1996.","journal-title":"J Immunol"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-2776(08)60387-9"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1038\/30989"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1038\/30996"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/31002"},{"key":"e_1_2_1_36_2","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.4049\/jimmunol.156.10.3952","article-title":"Activation of human monocytes through CD40 induces matrix metalloproteinases.","volume":"156","author":"Malik N.","year":"1996","unstructured":"MalikN. GreenfieldB.W. WahlA.F. KienerP.A.: Activation of human monocytes through CD40 induces matrix metalloproteinases. J Immunol, 156: 3952\u20133960, 1996.","journal-title":"J Immunol"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1006\/excr.2001.5256"},{"key":"e_1_2_1_38_2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/PL00007320","article-title":"Endothelial function and hemostasis.","volume":"89","author":"Becker B.F.","year":"2000","unstructured":"BeckerB.F. HeindlB. KupattC. ZahlerS.: Endothelial function and hemostasis. Z Kardiol, 89: 160\u2013167, 2000.","journal-title":"Z Kardiol"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1521-4141(199801)28:01<90::AID-IMMU90>3.0.CO;2-5"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830260603"},{"key":"e_1_2_1_41_2","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.4049\/jimmunol.161.4.1901","article-title":"Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7.","volume":"161","author":"Nakajima A.","year":"1998","unstructured":"NakajimaA. KodamaT. MorimotoS. AzumaM. TakedaK. OshimaH. YoshinoS. YagitaH. OkumuraK.: Antitumor effect of CD40 ligand: elicitation of local and systemic antitumor responses by IL-12 and B7. J Immunol, 161: 1901\u20131907, 1998.","journal-title":"J Immunol"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050583"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1038\/10503"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.12.6633"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.5.1927"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1997.8.16-1935"},{"key":"e_1_2_1_47_2","first-page":"2261","article-title":"Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines.","volume":"5","author":"Posner M.R.","year":"1999","unstructured":"PosnerM.R. CavaciniL.A. UptonM.P. TillmanK.C. GornsteinE.R. NorrisC.M. J.R.: Surface membrane-expressed CD40 is present on tumor cells from squamous cell cancer of the head and neck in vitro and in vivo and regulates cell growth in tumor cell lines. Clin Cancer Res, 5: 2261\u20132270, 1999.","journal-title":"Clin Cancer Res"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006012607452"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5699(98)01340-1"},{"key":"e_1_2_1_50_2","first-page":"1843","article-title":"Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells.","volume":"4","author":"Lollini P.L.","year":"1998","unstructured":"LolliniP.L. LanduzziL. FrabettiF. RossiI. NicolettiG. ScotlandiK. SerraM. BaldiniN. De GiovanniC. NanniP.: Expression of functional CD40 on human osteosarcoma and Ewing's sarcoma cells. Clin Cancer Res, 4: 1843\u20131849, 1998.","journal-title":"Clin Cancer Res"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0952-7915(00)00147-3"},{"key":"e_1_2_1_52_2","first-page":"1287","article-title":"Stimulation of CD40 on immunogenic human malignant melanoma augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis.","volume":"59","author":"von Leoprechting A.","year":"1999","unstructured":"von LeoprechtingA. van der BruggenP. PahlH.L. AruffoA. SimonJ.C.: Stimulation of CD40 on immunogenic human malignant melanoma augments their cytotoxic T lymphocyte-mediated lysis and induces apoptosis. Cancer Res, 59: 1287\u20131294, 1999.","journal-title":"Cancer Res"},{"key":"e_1_2_1_53_2","first-page":"1953","article-title":"CD40 is a prognostic marker in primary cutaneous malignant melanoma.","volume":"149","author":"van den Oord J.J.","year":"1996","unstructured":"van den OordJ.J. MaesA. StasM. NuytsJ. BattocchioS. KasranA. GarmynM. De WeverI. De Wolf-PeetersC.: CD40 is a prognostic marker in primary cutaneous malignant melanoma. Am J Pathol, 149: 1953\u20131961, 1996.","journal-title":"Am J Pathol"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002620050608"},{"key":"e_1_2_1_55_2","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.4049\/jimmunol.163.11.6201","article-title":"Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma.","volume":"163","author":"Biancone L.","year":"1999","unstructured":"BianconeL. CantaluppiV. BoccellinoM. Del SorboL. RussoS. AlbiniA. StamenkovicI. CamussiG.: Activation of CD40 favors the growth and vascularization of Kaposi's sarcoma. J Immunol, 163: 6201\u20136208, 1999.","journal-title":"J Immunol"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.12.3801"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.164.10.5055"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-5890(00)00079-1"},{"key":"e_1_2_1_59_2","first-page":"7556","article-title":"Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin.","volume":"61","author":"Ghamande S.","year":"2001","unstructured":"GhamandeS. HylanderB.L. OflazogluE. LeleS. FanslowW. RepaskyE.A.: Recombinant CD40 ligand therapy has significant antitumor effects on CD40-positive ovarian tumor xenografts grown in SCID mice and demonstrates an augmented effect with cisplatin. Cancer Res, 61: 7556\u20137562, 2001.","journal-title":"Cancer Res"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-472X(01)00668-3"},{"key":"e_1_2_1_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)65928-9"},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700315"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2001.25757"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1089\/104303401300057360"},{"key":"e_1_2_1_65_2","first-page":"691","article-title":"Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer.","volume":"7","author":"Tong A.W.","year":"2001","unstructured":"TongA.W. PapayotiM.H. NettoG. ArmstrongD.T. OrdonezG. LawsonJ.M. StoneM.J.: Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. Clin Cancer Res, 7: 691\u2013703, 2001.","journal-title":"Clin Cancer Res"},{"key":"e_1_2_1_66_2","first-page":"6391","article-title":"Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells.","volume":"60","author":"Kikuchi T.","year":"2000","unstructured":"KikuchiT. MiyazawaN. MooreM.A. CrystalR.G.: Tumor regression induced by intratumor administration of adenovirus vector expressing CD40 ligand and naive dendritic cells. Cancer Res, 60: 6391\u20136395, 2000.","journal-title":"Cancer Res"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.9.2917"},{"key":"e_1_2_1_68_2","first-page":"5456","article-title":"Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model.","volume":"60","author":"Tillman B.W.","year":"2000","unstructured":"TillmanB.W. HayesT.L. DeGruijlT.D. DouglasJ.T. CurielD.T.: Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Cancer Res, 60: 5456\u20135463, 2000.","journal-title":"Cancer Res"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301264"},{"key":"e_1_2_1_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301228"},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V96.1.91"},{"key":"e_1_2_1_72_2","first-page":"3225","article-title":"Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14.","volume":"60","author":"Francisco J.A.","year":"2000","unstructured":"FranciscoJ.A. DonaldsonK.L. ChaceD. SiegallC.B. WahlA.F.: Agonistic properties and in vivo antitumor activity of the anti-CD40 antibody SGN-14. Cancer Res, 60: 3225\u20133231, 2000.","journal-title":"Cancer Res"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V95.4.1258.004k18_1258_1263"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018049"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/8426"},{"key":"e_1_2_1_76_2","first-page":"433","article-title":"CD40 stimulation inhibits cell growth and Fas-mediated apoptosis in a thyroid cancer cell line.","volume":"10","author":"Fujieda S.","year":"1998","unstructured":"FujiedaS. SugimotoC. SekiM. SunagaH. SaitoH.: CD40 stimulation inhibits cell growth and Fas-mediated apoptosis in a thyroid cancer cell line. Oncol Res, 10: 433\u2013439, 1998.","journal-title":"Oncol Res"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1006012607452"},{"key":"e_1_2_1_78_2","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.161.9.4563","article-title":"CD40 ligand\/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge.","volume":"161","author":"Gurunathan S.","year":"1998","unstructured":"GurunathanS. IrvineK.R. WuC.Y. CohenJ.I. ThomasE. PrussinC. RestifoN.P. SederR.A.: CD40 ligand\/trimer DNA enhances both humoral and cellular immune responses and induces protective immunity to infectious and tumor challenge. J Immunol, 161: 4563\u20134571, 1998.","journal-title":"J Immunol"},{"key":"e_1_2_1_79_2","first-page":"163","article-title":"Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells.","volume":"5","author":"Couderc B.","year":"1998","unstructured":"CoudercB. ZitvogelL. Douin-EchinardV. DjennaneL. TaharaH. FavreG. LotzeM.T. RobbinsP.D.: Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells. Cancer Gene Ther, 5: 163\u2013175, 1998.","journal-title":"Cancer Gene Ther"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI1472"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.18.8200"},{"key":"e_1_2_1_82_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)90130-7"},{"key":"e_1_2_1_83_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.13.3280"}],"container-title":["Tumori Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/030089160208800502","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/030089160208800502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:23:26Z","timestamp":1777659806000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/030089160208800502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,9]]},"references-count":82,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2002,9]]}},"alternative-id":["10.1177\/030089160208800502"],"URL":"https:\/\/doi.org\/10.1177\/030089160208800502","relation":{},"ISSN":["0300-8916","2038-2529"],"issn-type":[{"value":"0300-8916","type":"print"},{"value":"2038-2529","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,9]]}}}